Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells.
Magkouta S, Veroutis D, Pousias A, Papaspyropoulos A, Pippa N, Lougiakis N, Kambas K, Lagopati N, Polyzou A, Georgiou M, Chountoulesi M, Pispas S, Foutadakis S, Pouli N, Marakos P, Kotsinas A, Verginis P, Valakos D, Mizi A, Papantonis A, Vatsellas G, Galanos P, Bartek J, Petty R, Serrano M, Thanos D, Roussos C, Demaria M, Evangelou K, Gorgoulis VG. Magkouta S, et al. Among authors: lougiakis n. Mol Cell. 2023 Oct 5;83(19):3558-3573.e7. doi: 10.1016/j.molcel.2023.09.006. Mol Cell. 2023. PMID: 37802028
NMR study of 5-substituted pyrazolo[3,4-c]pyridine derivatives.
Tsikouris O, Bartl T, Tousek J, Lougiakis N, Tite T, Marakos P, Pouli N, Mikros E, Marek R. Tsikouris O, et al. Among authors: lougiakis n. Magn Reson Chem. 2008 Jul;46(7):643-9. doi: 10.1002/mrc.2226. Magn Reson Chem. 2008. PMID: 18383434
Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents.
Lougiakis N, Papapetropoulos A, Gikas E, Toumpas S, Efentakis P, Wedmann R, Zoga A, Zhou Z, Iliodromitis EK, Skaltsounis AL, Filipovic MR, Pouli N, Marakos P, Andreadou I. Lougiakis N, et al. J Med Chem. 2016 Mar 10;59(5):1776-90. doi: 10.1021/acs.jmedchem.5b01223. Epub 2016 Feb 8. J Med Chem. 2016. PMID: 26809888
Novel pyrazolopyridine derivatives as potential angiogenesis inhibitors: Synthesis, biological evaluation and transcriptome-based mechanistic analysis.
Michailidou M, Giannouli V, Kotsikoris V, Papadodima O, Kontogianni G, Kostakis IK, Lougiakis N, Chatziioannou A, Kolisis FN, Marakos P, Pouli N, Loutrari H. Michailidou M, et al. Among authors: lougiakis n. Eur J Med Chem. 2016 Oct 4;121:143-157. doi: 10.1016/j.ejmech.2016.05.035. Epub 2016 May 20. Eur J Med Chem. 2016. PMID: 27240270
The discovery of new cytotoxic pyrazolopyridine derivatives.
Giannouli V, Lougiakis N, Kostakis IK, Pouli N, Marakos P, Skaltsounis AL, Nam S, Jove R, Horne D, Tenta R, Pratsinis H, Kletsas D. Giannouli V, et al. Among authors: lougiakis n. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5229-5233. doi: 10.1016/j.bmcl.2016.09.056. Epub 2016 Sep 24. Bioorg Med Chem Lett. 2016. PMID: 27720292
Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα Enzyme.
Daniilides K, Lougiakis N, Evangelidis T, Kostakis IK, Pouli N, Marakos P, Mikros E, Skaltsounis AL, Bach S, Baratte B, Ruchaud S, Karamani V, Papafotika A, Christoforidis S, Argyros O, Kouvari E, Tamvakopoulos C. Daniilides K, et al. Among authors: lougiakis n. Anticancer Agents Med Chem. 2017;17(7):990-1002. doi: 10.2174/1871520616666161207143450. Anticancer Agents Med Chem. 2017. PMID: 27928955
33 results